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A Corrigendum on
Hypocoagulability and Platelet Dysfunction Are Exacerbated by Synthetic Colloids in a Canine
Hemorrhagic Shock Model
by Boyd, C. J., Claus, M. A., Raisis, A. L., Hosgood, G., Sharp, C. R., and Smart, L. (2018). Front. Vet.
Sci. 5:279. doi: 10.3389/fvets.2018.00279
In the original article, there was amistake inTable 2 as published.The EXTEMCFT baselinemean
(95% confidence interval) for theHES groupwas slightly incorrect due to a data entry error.The
corrected Table 2 appears below.
In the original article, there was a mistake in Table 5 as published. The EXTEM CFT baseline
mean (95% confidence interval) was slightly incorrect due to a data entry error. The corrected
Table 5 appears below.
In the original article, there was an error. A conversion factor was inadvertently omitted from
the equation for thrombodynamic potential index (TPI).
A correction has been made toMaterials and Methods, Coagulation Parameters, Paragraph 3:
Rotational thromboelastometry (ROTEM R© delta, Tem International GmbH) was performed
according to the manufacturer’s instructions and PROVETS guidelines (28) using the INTEM
(star-TEM and in-TEM reagents), EXTEM (star-TEM and r ex-TEM reagents), FIBTEM (r ex-TEM
and fib-TEM reagents), and APTEM (r ex-TEM and ap-TEM reagents) profiles. Measurement was
started 30min after sample collection. Each profile was run for at least 1 h following initiation.
Data recorded for the INTEM and EXTEM profiles included clotting time (CT), clot formation
time (CFT), alpha angle (α), maximum clot firmness (MCF), and lysis index at 60min (LI60).
Thrombodynamic potential index (TPI) was recorded for the EXTEM profile as a measure of global
coagulation (29), calculated using the equations:
TPI = EMX∗30/CFT,
EMX = (100∗MCF)/(100−MCF).
The authors apologize for this error and state that this does not change the scientific conclusions of
the article in any way. The original article has been updated.
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TABLE 2 | Rotational thromboelastometry parameters (mean, 95% confidence interval) in dogs (n = 6 per group) with hemorrhagic shock given 20mL kg−1 of either fresh
whole blood (FWB), hydroxyethyl starch 130/0.4 (HES), 4% succinylated gelatin (GELO), or 80mL kg−1 of balanced isotonic crystalloid (CRYST).
Parameter Baseline Shock T60 T180
INTEM CT (sec)
FWB 279.3 (137.5–421.2) 204.8 (123.1–286.5) 330.5 (17.2–643.8) 269.0 (150.7–387.3)
CRYST 171.3 (149.1–193.5) 160.7 (129.2–192.1) 162.2 (134.0–190.3) 159.8 (142.8–176.9)
HES 201.2 (129.1–273.2) 145.8 (72.2–219.5) 231.8 (130.4–333.3) 199.0 (113.0–285.0)
GELO 221.5 (146.0–297.0) 161.0 (117.0–205.0) 224.3 (108.6–340.1) 193.5 (146.5–240.5)
INTEM CFT (sec)
FWB 224.2 (143.1–305.2) 260.3 (180.6–340.0) 303.8 (102.0–505.7) 235.3 (178.9–291.8)
CRYST 143.5 (119.1–167.9) 227.8 (190.9–264.8) 298.8 (269.5–328.1) 234.5 (207.6–261.4)
HES 202.8 (106.9–298.8) 264.0 (168.0–360.0) 431.5 (287.3–575.7) 309.2 (221.0–397.3)
GELO 178.2 (128.4–227.9) 186.2 (114.2–258.1) 305.5 (211.1–399.9) 278.7 (178.1–379.2)
INTEM α (◦)
FWB 54.2 (44.9–63.4) 54.0 (46.3–61.7) 52.7 (38.5–66.8) 56.2 (49.8–62.6)
CRYST 68.0 (65.4–70.6) 62.7 (57.2–68.1) 56.8 (53.7–60.0) 60.7 (59.8–61.5)
HES 60.5 (49.4–71.6) 56.0 (46.5–65.5) 50.7 (40.2–61.1) 53.5 (46.4–60.6)
GELO 61.2 (56.5–65.9) 61.7 (53.8–69.6) 53.0 (46.7–59.3) 56.2 (49.8–62.6)
INTEM MCF (mm)
FWB 51.2 (46.9–55.4) 47.7 (43.0–52.3) 45.3 (38.3–52.3)+ 48.2 (44.5–51.8)+
CRYST 54.2 (50.8–57.5) 46.3 (43.0–49.7) 42.2 (39.9–44.4) 44.0 (41.4–46.6)
HES 50.3 (45.3–55.4) 44.5 (40.3–48.7) 37.0 (31.6–42.4)& 41.0 (36.2–45.8)&
GELO 54.0 (48.3–59.7) 51.2 (45.8–56.5) 41.5 (36.0–47.0) 42.8 (37.2–48.5)
INTEM LI60 (%)
FWB 99.0 (97.4–100.6) 99.7 (98.8–100.5) 99.7 (98.8–100.5) 99.2 (97.9–100.4)
CRYST 99.7 (98.8–100.5) 98.7 (97.6–99.8) 96.8 (94.7–99.0) 97.2 (94.4–99.9)
HES 99.2 (97.9–100.4) 98.5 (96.4–100.6) 87.8 (67.3–108.4) 90.0 (74.1–105.9)
GELO 99.5 (98.6–100.4) 99.7 (99.1–100.2) 98.3 (94.0–102.6) 96.5 (87.5–105.5)
EXTEM CT (sec)
FWB 52.5 (40.8–64.2) 75.2 (57.2–93.1) 64.7 (45.3–84.1)+ 62.0 (53.1–70.9)
CRYST 54.8 (37.8–71.9) 66.2 (59.4–72.9) 72.8 (62.9–82.8)+ 71.5 (58.7–84.3)
HES 61.8 (40.6–83.0) 69.0 (56.1–81.9) 119.3
(57.4–181.3)&,*,#
82.7 (50.6–114.8)
GELO 47.8 (28.6–67.0) 55.8 (36.1–75.6) 76.2 (27.5–124.8)+ 75.2 (50.6–99.8)
EXTEM CFT (sec)
FWB 178.2 (121.5–234.8) 217.3 (149.5–285.2) 251.0 (127.6–374.4) 202.2 (148.5–255.9)
CRYST 129.3 (115.4–143.3) 184.2 (152.6–215.7) 246.0 (198.3–293.7) 221.0 (177.7–264.3)
HES 187.2 (106.0–268.3) 208.0 (137.8–278.2) 373.4 (179.9–566.9) 437.3 (0.0–918.6)
GELO 139.3 (102.6–176.1) 165.0 (115.5–214.5) 230.4 (167.7–293.1) 263.3 (174.5–352.1)
EXTEM α (◦)
FWB 59.8 (53.5–66.1) 60.0 (55.9–64.1) 55.8 (48.8–62.9) 58.3 (54.4–62.3)
CRYST 66.5 (64.4–68.6) 63.3 (60.9–65.8) 59.3 (54.2–64.5) 60.8 (59.0–62.6)
HES 61.7 (55.1–68.2) 61.8 (56.4–67.2) 46.2 (28.6–63.8) 53.0 (39.8–66.2)
GELO 65.7 (62.8–68.5) 63.5 (59.9–67.1) 49.5 (32.7–66.3) 56.0 (52.5–59.5)
EXTEM MCF (mm)
FWB 50.5 (46.3–54.7) 44.7 (39.6–49.7) 45.3 (38.6–52.1)+ 47.0 (43.4–50.6)
CRYST 54.7 (52.1–57.2) 45.7 (42.1–49.3) 39.0 (33.3–44.7) 39.3 (34.7–44.0)
HES 49.3 (42.7–55.9) 42.5 (33.4–51.6) 31.2 (20.5–41.9)& 37.8 (28.6–47.1)
GELO 54.3 (47.8–60.8) 50.0 (43.4–56.6)ß 39.0 (26.6–51.4) 40.3 (31.9–48.8)
EXTEM TPI
FWB 18.8 (12.7–25.0) 12.5 (6.7–18.3) 12.3 (5.6–19.0) 14.0 (9.6–18.4)
CRYST 28.5 (22.8–34.2) 14.3 (10.5–18.2) 8.2 (5.6–10.8) 9.3 (6.1–12.6)
HES 20.2 (7.4–32.9) 14.2 (1.1–27.3) 4.8 (2.0–7.6) 8.2 (1.4–14.9)
GELO 28.8 (15.3–42.4) 21.0 (10.3–31.7) 11.2 (5.3–17.1) 9.5 (4.2–14.8)
(Continued)
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TABLE 2 | Continued
Parameter Baseline Shock T60 T180
EXTEM LI60 (%)
FWB 89.3 (66.9–111.7) 78.7 (48.1–109.3) 90.7 (70.7–110.7) 91.0 (78.2–103.8)
CRYST 99.0 (97.9–100.1) 87.7 (73.0–102.3) 84.7 (52.9–116.5) 78.8 (58.5–99.2)
HES 98.3 (95.5–101.2) 83.3 (56.1–110.6) 74.3 (36.5–112.2) 84.3 (56.2–112.5)
GELO 97.5 (93.8–101.2) 86.7 (65.3–108.1) 75.8 (49.2–102.5) 72.5 (42.5–102.5)
FIBTEM MCF (mm)
FWB 4.3 (3.5–5.2) 3.5 (2.4–4.6) 3.3 (1.5–5.2) 2.8 (1.0–4.6)
CRYST 6.0 (3.1–8.9) 4.7 (1.9–7.5) 2.8 (1.0–4.6) 3.2 (1.2–5.1)
HES 5.0 (2.6–7.4) 2.0 (0.0–4.9) 0.7 (0.0–2.4) 2.2 (0.0–5.2)
GELO 4.8 (3.3–6.4) 3.8 (2.3–5.4) 2.0 (0.2–3.8) 2.7 (1.1–4.2)
Fluid was delivered directly after Shock time point.
&Significantly different to FWB; *Significantly different to CRYST; +Significantly different to HES; #Significantly different to GELO (Bonferroni–Holm corrected P-value < 0.05). α, alpha
angle; CFT, clot formation time; CT, clotting time; LI60, lysis index at 60min; MCF, maximum clot firmness; TPI, thrombodynamic potential index.
TABLE 5 | Platelet closure time and count, rotational thromboelastometry, and plasma coagulation assay parameters (mean, 95% confidence interval) in dogs (n = 24)
with hemorrhagic shock.
Parameter Baseline Shock P value*
Platelet Closure Time (sec) 83.4 (77.6–89.1) 69.0 (65.2–72.8) <0.001
Estimated Platelet Count (x109 L−1) 134.3 (124.7–143.9) 119.4 (106.3–132.5) 0.057
INTEM CT (sec) 218.3 (180.9–255.7) 168.1 (143.2–193.0) <0.001
INTEM CFT (sec) 158.5 (135.9–181.1) 234.6 (203.6–265.6) <0.001
INTEM α (◦) 61.0 (57.4–64.5) 58.6 (55.3–61.9) 0.067
INTEM MCF (mm) 52.4 (50.5–54.3) 47.4 (45.4–49.4) <0.001
INTEM LI60 (%) 99.3 (98.9–99.8) 99.1 (98.6–99.7) 0.458
EXTEM CT (sec) 54.3 (47.3–61.2) 66.5 (60.1–73.0) <0.001
EXTEM CFT (sec) 148.0 (125.3–170.7) 193.6 (170.5–216.8) <0.001
EXTEM α (◦) 63.4 (61.2–65.6) 62.2 (60.5–63.8) 0.117
EXTEM MCF (mm) 52.2 (50.0–54.4) 45.7 (43.0–48.4) <0.001
EXTEM LI60 (%) 96.0 (91.4–100.7) 84.1 (74.9–93.3) 0.002
EXTEM TPI 24.1 (19.8–28.4) 15.5 (11.8–19.2) <0.001
FIBTEM MCF (mm) 5.0 (4.2–5.9) 3.5 (2.6–4.4) <0.001
Prothrombin Time (sec) 7.5 (7.3–7.7) 8.5 (8.2–8.8) <0.001
Activated Partial Thromboplastin Time (sec) 15.4 (14.8–16.0) 14.4 (13.6–15.1) <0.001
Fibrinogen Concentration (g L−1) 1.41 (1.29–1.54) 0.97 (0.87–1.08) <0.001
Factor VII Activity (%) 99.1 (92.5–105.7) 77.8 (71.7–84.0) <0.001
Factor VIII Activity (%) 109.8 (98.0–121.6) 155.4 (139.9–171.0) <0.001
von Willebrand Factor Antigen (%) 100.6 (90.0–111.3) 74.3 (60.2–88.4) <0.001
*Paired t-test, bold indicates P < 0.05. α, alpha angle; CFT, clot formation time; CT, clotting time; LI60, lysis index at 60min; MCF, maximum clot firmness; TPI, thrombodynamic
potential index.
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